Biblio
“Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.”, J Alzheimers Dis, 2015.
, “Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 57, no. 2, pp. 519-530, 2017.
, “Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?”, J Alzheimers Dis, vol. 52, no. 2, pp. 417-20, 2016.
, “Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.”, J Alzheimers Dis, vol. 68, no. 2, pp. 571-582, 2019.
, “Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 525-532, 2018.
, “Amyloid-Directed Antibodies: Past, Present, and Future.”, J Alzheimers Dis, vol. 101, no. s1, pp. S3-S22, 2024.
, “Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.”, J Alzheimers Dis, vol. 57, no. 4, pp. 975-999, 2017.
, “The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.”, J Alzheimers Dis, vol. 74, no. 3, pp. 829-837, 2020.
, “Amyloid Plaques Show Binding Capacity of Exogenous Injected Amyloid-β.”, J Alzheimers Dis, vol. 55, no. 1, pp. 147-157, 2017.
, “Amyloid Hypothesis: The Emperor's New Clothes?”, J Alzheimers Dis, vol. 78, no. 4, pp. 1363-1366, 2020.
, “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
, “Amyloid Burden in Obstructive Sleep Apnea.”, J Alzheimers Dis, vol. 59, no. 1, pp. 21-29, 2017.
, “Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.”, J Alzheimers Dis, vol. 66, no. 1, pp. 307-318, 2018.
, “Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S633-S646, 2018.
, “Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 56, no. 1, pp. 47-61, 2017.
, “Amylin Enhances Amyloid-β Peptide Brain to Blood Efflux Across the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1087-1099, 2017.
, “Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 669-674, 2017.
, “Amsterdam Dementia Cohort: Performing Research to Optimize Care.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
, “Amnestic Syndrome in Memory Clinics: Similar Morphological Brain Patterns in Older Adults with and without Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 333-343, 2024.
, “Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.”, J Alzheimers Dis, vol. 73, no. 1, pp. 63-71, 2020.
, “Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.”, J Alzheimers Dis, vol. 60, no. 3, pp. 1077-1085, 2017.
, “Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1303-1312, 2021.
, “Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline.”, J Alzheimers Dis, vol. 104, no. 3, pp. 667-677, 2025.
, “Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.”, J Alzheimers Dis, vol. 75, no. 4, pp. 1361-1376, 2020.
, “Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.”, J Alzheimers Dis, vol. 58, no. 3, pp. 821-828, 2017.
,